Supernus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 8.70 M | $415.70 M | -7.15% | 15.53% |
| VANGUARD GROUP INC | 11/07/2025 | 6.04 M | $288.88 M | -2.59% | 10.79% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 3.00 M | $143.46 M | -0.64% | 5.36% |
| ARMISTICE CAPITAL, LLC | 11/17/2025 | 2.84 M | $135.53 M | -41.06% | 5.06% |
| MACQUARIE GROUP LTD | 11/13/2025 | 2.53 M | $120.98 M | -8.35% | 4.52% |
| STATE STREET CORP | 11/14/2025 | 2.19 M | $104.54 M | -0.95% | 3.90% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.76 M | $84.18 M | 246.89% | 3.14% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 1.74 M | $83.18 M | 5.15% | 3.11% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.42 M | $67.71 M | 709.05% | 2.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.41 M | $67.39 M | 0.74% | 2.52% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 10/28/2025 | 1.35 M | $64.30 M | -14.91% | 2.40% |
| LOOMIS SAYLES & CO L P | 11/13/2025 | 1.29 M | $61.45 M | -0.92% | 2.30% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.26 M | $60.40 M | 63.50% | 2.26% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.16 M | $55.58 M | 29.75% | 2.08% |
| GW&K INVESTMENT MANAGEMENT, LLC | 11/12/2025 | 1.08 M | $51.64 M | -14.57% | 1.93% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 979.60 K | $46.82 M | 63.64% | 1.75% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 842.89 K | $40.28 M | 67.14% | 1.50% |
| MORGAN STANLEY | 11/14/2025 | 755.32 K | $36.10 M | 8.87% | 1.35% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 732.49 K | $35.01 M | -2.16% | 1.31% |
| NORTHERN TRUST CORP | 11/14/2025 | 703.56 K | $33.62 M | -0.96% | 1.26% |
| RUBRIC CAPITAL MANAGEMENT LP | 11/14/2025 | 595.37 K | $28.45 M | -14.34% | 1.06% |
| ASHFORD CAPITAL MANAGEMENT INC | 11/14/2025 | 563.72 K | $26.94 M | -1.85% | 1.01% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 559.84 K | $26.75 M | -25.51% | 1.00% |
| UBS GROUP AG | 11/13/2025 | 540.12 K | $25.81 M | 137.58% | 0.96% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 509.37 K | $24.34 M | -44.40% | 0.91% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 508.93 K | $24.23 M | -8.22% | 0.91% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/16/2025 | 476.08 K | $22.75 M | -9.26% | 0.85% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 415.69 K | $19.87 M | 37.34% | 0.74% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 377.07 K | $18.02 M | -52.82% | 0.67% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 376.60 K | $18.00 M | -5.23% | 0.67% |
| KRENSAVAGE ASSET MANAGEMENT, LLC | 11/17/2025 | 363.48 K | $17.37 M | -23.05% | 0.65% |
| INVESCO LTD. | 11/13/2025 | 361.87 K | $17.29 M | -9.31% | 0.65% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 346.29 K | $16.55 M | 2,548.92% | 0.62% |
| ARISTOTLE CAPITAL BOSTON, LLC | 11/14/2025 | 305.27 K | $14.59 M | -62.24% | 0.54% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 303.41 K | $14.50 M | -0.73% | 0.54% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 11/13/2025 | 292.26 K | $13.97 M | 19.03% | 0.52% |
| CATALIO CAPITAL MANAGEMENT, LP | 11/14/2025 | 287.09 K | $13.72 M | 100.00% | 0.51% |
| NUVEEN, LLC | 11/12/2025 | 286.05 K | $13.67 M | 158.10% | 0.51% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 257.98 K | $12.33 M | 350.18% | 0.46% |
| BARCLAYS PLC | 11/12/2025 | 231.19 K | $11.05 M | 64.03% | 0.41% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 226.41 K | $10.82 M | -8.70% | 0.40% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 224.14 K | $10.70 M | 2,343.24% | 0.40% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 218.68 K | $10.45 M | -0.74% | 0.39% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 206.90 K | $9.89 M | 100.00% | 0.37% |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 10/31/2025 | 199.26 K | $9.52 M | -6.32% | 0.36% |
| PACER ADVISORS, INC. | 10/15/2025 | 190.89 K | $9.12 M | -33.77% | 0.34% |
| THIRD AVENUE MANAGEMENT LLC | 11/14/2025 | 189.49 K | $9.10 M | 0.00% | 0.34% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 183.32 K | $8.76 M | 5.86% | 0.33% |
| JPMORGAN CHASE & CO | 11/26/2025 | 171.29 K | $8.19 M | -45.64% | 0.31% |
| RHUMBLINE ADVISERS | 11/06/2025 | 169.80 K | $8.11 M | -1.41% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Supernus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 457 institutional investors and hedge funds held shares of Supernus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 8.7 M
VANGUARD GROUP INC: 6.04 M
DIMENSIONAL FUND ADVISORS LP: 3 M
ARMISTICE CAPITAL, LLC: 2.84 M
MACQUARIE GROUP LTD: 2.53 M
STATE STREET CORP: 2.19 M
102.96% of Supernus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 81.33 M shares in the last 24 months. This purchase volume represents approximately $3.93 B in transactions.